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Abstract
Objective: The usual procedure for obtaining material
for histological analysis for the diagnosis of peripheral
carcinoma of the lung is transbronchial forceps biopsy
(TBB). Not widely spread is acquiring samples for cy-
tological examination by transbronchial catheter aspi-
ration (TBCA). Data were retrospectively collected to
determine the diagnostic sensitivity of TBCA in com-
parison with TBB concerning malignancy.
Methods: We analysed the results of 51 consecutively
examined patients (age 68.7 ﾱ 8.8 yrs.) applying both
methods. 48 of 51 peripheral lesions proved to be ma-
lignant, 34 of which measured > 3 cm in diameter and
14 ≤ 3 cm. Fluoroscopy provided guidance in biopsies
for both techniques.
Results: The mean diameter of the lesion was 3.7 ﾱ
1.5 cm. We were able to establish a correct diagnosis
by TBCA in 36 of 48 patients with lung cancer, and in
21 of 48 patients by TBB (75% vs. 44%, p < 0.01,
chi-square-test). By combination of both methods 39
of 48 patients were correctly diagnosed. For carcino-
ma > 3 cm the success rate for TBCA was 76%
(26/34) and for TBB 56% (19/34). For carcinoma ≤ 3
cm the success rate for TBCA was 71% (10/14) and
for TBB 14% (2/14).
Conclusions: Even in lesions ≤ 3 cm application of
TBCA results in an only marginally lower success rate
compared to lesions > 3 cm. Due to the overall high
success rate we suggest to apply the easy-to-handle
and inexpensive method of TBCA in diagnostic pro-
cedure of peripheral lung carcinoma.
Key words: lung cancer; transbronchial biopsy; trans-
bronchial catheter aspiration; peripheral pulmonary le-
sions; bronchoscopy
Abbreviations: BB: bronchial brushing, EBUS: endo-
bronchial ultrasound, ENB: electromagnetic naviga-
tion bronchoscopy, TBB: transbronchial forceps biop-
sy, TBCA: transbronchial catheter aspiration, TBNA:
transbronchial needle aspiration
INTRODUCTION
The most established diagnostic procedure for detect-
ing peripheral lesions of the lung is the extraction of
tissue for histological examination by transbronchial
forceps biopsy (TBB) under fluoroscopy control with a
diagnostic sensitivity between 32 and 57% [1, 2]. Sever-
al studies were able to prove an amelioration of success
rates by addition of cytological methods such as trans-
bronchial needle aspiration (TBNA), bronchial brush-
ing (BB) and bronchial washing (BW) [3, 4, 5]. For
TBNA a significantly higher yield was reported in com-
parison with TBB [1, 6]. The high specifity of cytologic
methods in lung carcinoma is confirmed [2, 3, 7-10].
A less widely spread technique of acquiring cyto-
logical samples is transbronchial catheter aspiration
(TBCA) that was introduced 1961 and continued in
modernized technique [11, 12]. Sample material is me-
chanically mobilized and aspirated through the ra-
diopaque catheter which is pushed forward into the le-
sion. The blunt distal end of the catheter implies low
complication rates, there is no risk to impare the work-
ing channel. The costs of this method are low, because
the catheter is reusable. It is easy to handle and can be
performed outside the expert centers as well.
Diagnostic sensitivity of bronchoscopic methods in
lung carcinoma with no corresponding airway abnor-
malities varies widely between 24 and 82% [6, 13],
mainly dependent on the size of lesion, largest differ-
ence at 3 centimeters [1, 4, 6, 13]. Modern, more com-
plex methods of guidance, such as endobronchial ul-
trasound (EBUS) and electromagnetic navigation
bronchoscopy (ENB), can improve success rates espe-
cially in small peripheral lesions < 3 cm that can fre-
quently not be detected under fluoroscopy [13-16].
Disadvantageous are high costs and additional expense
relating to the apparatus.
In comparison with TBB, TBCA showed a higher
diagnostic sensitivity in a study on 28 cases [17]. The
objective of the presented study was to corroborate
the diagnostic value of TBCA in endoscopically not
visible lung carcinoma compared directly to TBB. An
additional goal was to evaluate in which manor the
yield of TBCA is affected by the size of the lesion.
METHODS
STUDY DESIGN
We evaluated 51 consecutive patients between January
and December 2004 with pulmonary nodules or mass-
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approach underwent both TBB and TBCA. Informed
consent was obtained in all patients prior to the proce-
dure. Permission was obtained from the Institutional
Review Board at the University of Witten/Herdecke
to review and publish patient records retrospectively.
Only patients without endobronchial visible tumour at
bronchoscopy were included in the study. In every
case TBCA was performed first, followed by TBB.
The number of TBB and TBCA was noted directly af-
ter bronchoscopy. Location of the lesion was deter-
mined from the radiographs and the CT. The largest
dimension of the lesion in mm was measured.
BRONCHOSCOPY
Beside an anaesthesia of the bronchial system with li-
docaine (2% solution), midazolam was used in mini-
mum amounts when necessary. Fluoroscopy was pro-
vided using a C-arm. We used videoendoscopes with
an external diameter of 6.2 mm (Pentax Europe).
Biopsies were performed with regular disposable biop-
sy forceps and a catheter with a diameter of 2.3 mm,
which is visible under fluoroscopy (Wieser, Egen-
hofen, Germany). We aspirated the cytological sample
into the tip of the catheter by a few vigorous back-
and-forth movements while suction was performed
with a 10-ml syringe. The forceps biopsy samples were
placed in formalin and the content of the catheter was
given into 70% alcohol and sent in for histological and
cytological examination, respectively.
FOLLOW-UP
Surgical pathologic diagnosis was compared with the
bronchoscopic diagnosis in patients who underwent
subsequent resection. A clinical follow-up was done
for 3 years.
STATISTICAL ANALYSIS
Results were compared using the chi-square test. Data
are presented as mean ﾱ SD.
RESULTS
We examined 51 patients with an average age of 68.7
ﾱ 8.8 yrs. The mean diameter of the lesion was 3.7 ﾱ
1.5 cm. The number of samples obtained by catheter
aspiration was 2.8 ﾱ 1.0 and the number of samples
obtained by forceps biopsy was 3.2 ﾱ 1.4.
After bronchoscopy, 20 of 51 patients received a
subsequent surgical biopsy, in 3 of 51 patients percu-
taneous transthoracic biopsy was performed, in 28 of
51 patients clinical follow-up was done for 3 years.
In 12 of 20 cases with surgical biopsy broncho-
scopical diagnosis of malignancy was confirmed, in 6
patients with nondiagnostic bronchoscopy surgical
biopsy was able to resolve diagnosis of malignancy, 1
tumour was proved by thoracotomy to be benign.
There was 1 false positive result by catheter aspiration
from the right lower lobe (adeno carcinoma), proved
by surgical pathologic diagnosis as chronic pneumonia.
In 1 of 3 cases with percutaneous transthoracic
biopsy bronchoscopical diagnosis of malignancy was
confirmed, in 2 patients with nondiagnostic bron-
choscopy percutaneous transthoracic biopsy was able
to resolve diagnosis of malignancy.
In 26 of 28 patients bronchoscopical diagnosis of
lung cancer was corroborated by clinical follow up for
3 years. 1 patient with nondiagnostic bronchoscopy
died of lung cancer and 1 lesion was remarked as be-
nign, because the tumor size had not increased after 3
years. Both patients had not agreed to a surgical proce-
dure.
Sensitivity and specificity of bronchoscopy in rela-
tion to malignancy proved by surgical biopsy, trans-
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Table 1. Yield by bronchoscopy in relation to malignancy proved by surgical biopsy, transthoracic biopsy and clinical follow-up.
Yield by bronchoscopy n=51
Surgical biopsy Transthoracic biopsy Clinical follow-up
n = 20 n = 3 n = 28
True positive 12/20 1/3 26/28
False positive 1/20 0/3 0/28
True negative 1/20 0/3 1/28
False negative 6/20 2/3 1/28
Table 2. Size of peripheral lung cancer and yield.
Diagnostic sensitivity (%) by:
Carcinoma, Size Carcinoma, No. Forceps biopsy (TBB) Catheter aspiration (TBCA) Combination (TBB/TBCA)
All, 48 44 75 81
38,3 ﾱ 14,8 mm
Carcinoma ≤ 3 cm, 14 14 71 71
20,6 ﾱ 6,5 mm
Carcinoma > 3 cm, 34 56 76 85
45,6 ﾱ 10,4 mm
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Table 1.
Collectively, 48 of 51 patients were taken sick with
lung cancer. Bronchoscopical sampling achieved a de-
finitive diagnosis in 39 of 48 patients with lung cancer
(81%), in 21 cases the histological procedure was diag-
nostic (44%), and in 36 the cytological method (75%).
The yield of the cytological procedure of TBCA was
significantly higher than the yield obtained by TBB
(75% vs. 44%, p<0.001, chi-square-test).
Table 2 shows the diagnostic sensitivity in relation
to malignancy and the effect of size on the yield from
bronchoscopy. Diagnostic yield was higher for lesions
defined as mass (>3 cm size; 29/34, 85%) than for le-
sions defined as nodules (≤ 3 cm; 10/14, 71%). The
difference of the success rates of TBCA compared
with TBB was evidently greater in lesions ≤ 3 cm
(10/14, 71% vs. 2/14, 14%) than in lesions >3 cm in
diameter (26/34, 76% vs. 19/34, 56%).
Sensitivity and specificity of catheter aspiration
technique in our study are shown in Table 3.
The localisation of the peripheral nodule or mass
was the left upper lobe in 14 patients, the right upper
lobe in 17 patients, the middle lobe in 2 , the left lower
lobe in 5 and the right lower lobe in 10. Table 4 shows
the yield by location of the peripheral lesion in rela-
tion to malignancy.
No significant complications occured in our series
with either TBCA or TBB, such as pneumothorax or
bleeding requiring further action than the instillation
of noradrenalin.
DISCUSSION
1. Our study shows a significantly higher diagnostic
sensitivity of TBCA compared to TBB concerning
malignancy. On a larger sample and in smaller le-
sions than presented before [17], the data corrobo-
rates the superiority of TBCA.
2. Applying TBCA success rates are only marginally
lower in lesions ≤ 3 cm in comparison to lesions
> 3 cm (71 vs. 76%).
1. TBCA COMPARED TO TBB:
Success rates of TBB under fluoroscopy for peripher-
al lung carcinoma vary without regard to the size of
the lesion between 30 and 57% [2, 18]. We achieved a
sensitivity of 45% at average lesion size of 3.8 ﾱ 1.5
cm.
Previously TBNA has been the only cytological
method to achieve a higher sensitivity in comparison
with TBB (success rates concerning malignancy
TBNA vs. TBB: 46 vs. 32%, 62% vs. 38%, 69% vs.
54%) [1, 6, 7]. Besides the fact that less material is re-
quired for cytological confirmation of diagnosis per
se, the significantly higher success rate of TBCA may
result from the application of continuous catheter suc-
tion that allows to collect not only local sample mater-
ial, but also from a larger area of the region of inter-
est. The volume of biopsy of TBCA is augmented by
strong suction [12].
Most carcinoma are located in the upper lobes, in
our study 14/48 in the left, 17/48 in the right upper
lobe. The biggest difference of success rates between
TBB and TBCA concerning lobar localisation arises in
the right upper lobe: TBB yields a diagnostic sensitivi-
ty of 4/17, whereas TBCA reaches a sensitivity con-
cerning malignancy of 12/17. This can be explained
by a higher flexibility of the catheter compared to the
forceps allowing a better access of strongly distorted
subsegmental ostia.
Another advantage of TBCA compared to TBB
may be increasing difficulties to open the forceps the
more the airway is narrowing, while the tip of the
catheter probably does not lose its ability to injure the
surface of the lesion. TBNA and TBCA both are un-
derutilized procedures [19, 20]. Concerning TBCA, in
spite of its easy handling, little risk of damaging the
bronchoscope and low cost. The price of the catheter
is 37,37 EUR, it is reusable up to 40 times.
2. TBCA YIELD IN LESIONS ≤ 3 CM
For lung cancer < 2 cm success rates reported for TBB
are between 15 and 35% [21], the success rate in our
study was 14% for malignant lesions ≤ 3 cm. This may
be due to the fact, that small lesions are frequently not
visible in fluoroscopy, so that only regions of interest
can be explored. More recently developed methods of
guidance show outstanding sensitivity in these cases.
Using EBUS in combination with a guide sheath, 74%
(40/54) of peripheral lesions ≤ 2 cm invisible in fluo-
roscopy were diagnosed by TBB and BB [13]. In an-
other study 54 lesions were invisible in fluoroscopy, 48
of these were localized by EBUS; success rate of TBB
was 70% (38/48) at an average size of the lesions of
2.2 cm [15]. Recently reported, by use of EBUS with a
guide sheath without fluoroscopy the diagnostic sensi-
tivity for lesions with diameters of 2 to 3 cm was
57.9% (22/38), adding fluoroscopy the yield was
81.6% (31/38). Most of the lesions were located in the
right upper lobe, with lowest diagnostic yield [22].
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Table 3. Yield by catheter aspiration technique (n = 51).
True positive False positive
36/51 (70,59%) 1/51 (1,96%)
True negative False negative
2 (3,92%) 12 (23,53%)
Table 4. Location of the peripheral lung cancer.
Yield for malignant
disease obtained by:
n = 48 Forceps Catheter
biopsy aspiration
(TBB) (TBCA)
Left upper lobe 14 7 10
Right upper lobe 17 4 12
Middle lobe 212
Left lower lobe 544
Right lower lobe 10 58
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bronchoscopy (ENB), allows to direct the sampling
tool directly towards the peripheral lesion. At an aver-
age size of 2.28 cm per lesion a success rate of 74%
was achieved using BB, TBB or TBNA for sampling
methods; for tumor sizes 0 to 3 cm diagnostic gain was
72.09%, for peripheral lesion sizes > 3 cm it was
81.8% [16]. While 84 of 92 peripheral lesions were ≤3
cm, another study shows an overall positive diagnostic
yield of 67% using ENB without fluoroscopy [23].
Combining both EBUS and ENB the yield of TBB
without fluoroscopic guidance was 88%, independent
of lesion size or lobar distribution [24].
In our study we achieved diagnostic sensitivity of
71% vs. 76% concerning malignancy by TBCA in pe-
ripheral lesions of 0 to 3 cm size vs. > 3 cm with fluo-
roscopy and without general anesthesia. However, the
number of peripheral lung carcinoma ≤ 3 cm was only
14, 9 of which were located in the upper lobes. Suc-
cess rate by TBCA was 5 out of 9. All 5 carcinoma ≤ 3
cm of other localizations were diagnosed by TBCA.
This confirms the difficulty of diagnosing small le-
sions especially in apical upper lobe segments [4,6,15].
In contrast, there is a higher difference in success
rates of TBNA under fluoroscopy depending on tu-
mor size: peripheral lesions > 3 cm were reached,
compared to lesions < 3 cm in 69 vs. 50% (n = 37) [6]
respectively 67 vs. 28% (n=114) [1]. One reason can
be the lesser flexibility of the needle, another the fact
that TBNA allows targeted sampling only.
CONCLUSIONS
TBCA seems to represent an efficient and easy-to-
handle method for diagnosis of peripheral lung carci-
noma with a relatively good diagnostic yield indepen-
dent of lesion size, which can be performed outside
the expert centers as well. Catheters are inexpensive
with low costs per case of the whole procedure. Due
to these advantages, the use of this method could be
included in a sequential concept, that peripheral tu-
mours could first be diagnosed by TBCA under fluo-
roscopy. In case of negative results, in another step,
diagnosis could be established by EBUS- guided trans-
bronchial lung biopsy and/or ENB.
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